Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pediatr Emerg Care ; 28(10): 1062-5, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-23034494

RESUMO

Although international guidelines for hemodynamic support of pediatric septic shock suggest considering the potent calcium sensitizer inodilator levosimendan as a second-line inotropic agent to treat cold hypodynamic shock resistant to catecholamines, clinical experience in septic infants is lacking. We report the beneficial effects of levosimendan infusion in 2 infants (39 and 64 days old) with low cardiac output septic shock (ejection fraction, 29% and 33%; fractional shortening, 10% and 16% respectively) refractory to volume replacement and to the catecholamines dopamine and dobutamine. Levosimendan infusion (0.15 µg/kg/min) promptly increased both patients' myocardial contractility and improved tissue perfusion, thereby reducing lactate levels and increasing urine output. The only adverse effect was moderate hypotension in one infant, who reversed by adding norepinephrine to levosimendan. This clinical experience confirms the potential beneficial effects of levosimendan infusion to restore hemodynamics in infants with low cardiac output septic shock resistant to catecholamines.


Assuntos
Baixo Débito Cardíaco/tratamento farmacológico , Débito Cardíaco/efeitos dos fármacos , Hidrazonas/uso terapêutico , Piridazinas/uso terapêutico , Choque Séptico/complicações , Débito Cardíaco/fisiologia , Baixo Débito Cardíaco/etiologia , Baixo Débito Cardíaco/fisiopatologia , Cardiotônicos/administração & dosagem , Cardiotônicos/uso terapêutico , Humanos , Hidrazonas/administração & dosagem , Lactente , Infusões Intravenosas , Masculino , Contração Miocárdica/efeitos dos fármacos , Piridazinas/administração & dosagem , Simendana
3.
J Opioid Manag ; 5(4): 197-202, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19736899

RESUMO

Subarachnoid block is a widely used technique for cesarean section. Opioids adding to the local anesthetics can improve its quality. In this prospective, randomized, double blind, controlled trial, we compared the effects of coadministration of intrathecal sufentanil and morphine with intrathecal sufentanil and a single administration of subcutaneous morphine. Sixty-four pregnant women scheduled for elective cesarean section under spinal anesthesia were assigned to two groups according to the way of administration of morphine: intrathecal sufentanil (5 microg) plus intrathecal morphine (150 microg) (ITM group), and intrathecal sufentanil (5 microg) plus single administration of 10 mg subcutaneous morphine (SCM group). In both groups, the local anesthetic used was hyperbaric bupivacaine 0.5 percent (10 mg). Both groups received 1 g acetaminophen every 6 hours. In the postoperative period, pain was recorded on a 0-100 visual analog scale (VAS) and intravenous tramadol (100 mg) was administered if VAS score was >40 mm. Collateral effects, such as nausea, itching, respiratory depression, and sedation were assessed. VAS scores at rest and on coughing were significantly higher in the SCM group than in the ITM group between 3 and 24 hours. The mean titrated dose of tramadol consumed was also significantly greater in the SCM group than in the ITM group (p < 0.05). The time to first administration of tramadol was lower in the SCM group versus the ITM group (p < 0.05). The incidence of nausea was significantly lower in the SCM group than in the ITM group (p < 0.05). There was no significant group difference in the incidence of pruritus (p > 0.05). In conclusion, coadministration of sufentanil and morphine into the subarachnoid space was effective and provided longer pain relief than intrathecal sufentanil plus a single injection of subcutaneous morphine, despite a higher incidence of side effects such as nausea and vomiting.


Assuntos
Anestesia Obstétrica/métodos , Raquianestesia/métodos , Anestésicos Locais/farmacologia , Bupivacaína/farmacologia , Cesárea , Morfina/administração & dosagem , Dor Pós-Operatória/tratamento farmacológico , Sufentanil/administração & dosagem , Adulto , Método Duplo-Cego , Feminino , Humanos , Morfina/efeitos adversos , Gravidez , Sufentanil/efeitos adversos
4.
J Pediatr Surg ; 43(1): e29-32, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18206442

RESUMO

An exceptional case of tracheal agenesis with no communication with the esophagus is described. This malformation needs surgical airway approach and is hardly classifiable. We analyzed the literature and our institutional data: this resulted to be the first case of such anatomical variant. Genetic and pathological issues are reviewed: recent genetic data seem to explain this malformation. We also reviewed the available literature about prenatal presentation. Because prenatal diagnosis is difficult to achieve and current guidelines for neonatal resuscitation do not provide any recommendation, the resuscitative team may not be prepared for managing such a case. Usefulness of uncommon resuscitative maneuvers is discussed: a promptly performed surgical tracheotomy is the only mean to ventilate such a baby.


Assuntos
Anormalidades Múltiplas/diagnóstico , Reanimação Cardiopulmonar/métodos , Recém-Nascido Prematuro , Síndrome do Desconforto Respiratório do Recém-Nascido/diagnóstico , Traqueia/anormalidades , Anormalidades Múltiplas/terapia , Autopsia , Gasometria , Fístula Esofágica , Evolução Fatal , Humanos , Recém-Nascido , Unidades de Terapia Intensiva Neonatal , Masculino , Respiração Artificial/métodos , Síndrome do Desconforto Respiratório do Recém-Nascido/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...